AbbVie(DE:4AB)
€266.60-1.50 (-0.56%)
DE:4AB
AbbVie earnings date
€266.60
At close:-1.50 (-0.56%)
AbbVie (4AB) Q3 2024 Earnings Report
28 Followers
DE:4AB Q3 2024 EPS Results
- Actual EPS
- EUR 2.72
- Consensus EPS
- EUR 2.65
- Beat/Miss
- Beat by +EUR 0.07
- One Year Ago EPS
- EUR 2.68
DE:4AB Q3 2024 Revenue Results
- Actual Revenue
- EUR 13.12B
- Expected Revenue
- EUR 12.96B
- Beat/Miss
- Beat by +EUR 161.19M
- YoY Revenue Growth
- +3.83%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/30/2024
- Time
- Before Open
- Conference Call
- Wednesday, October 30, 2024
DE:4AB Upcoming Earnings
AbbVie's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
DE:4AB Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4AB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 3.53- | 2.46 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | 3.383.47 | 1.69 | 105.38% (+1.78) | |
| Jul 31, 2026 | 2026 (Q2) | 3.273.31 | 2.69 | 22.90% (+0.62) | |
| Apr 29, 2026 | 2026 (Q1) | 2.352.40 | 2.23 | 7.72% (+0.17) | |
| Feb 04, 2026 | 2025 (Q4) | 2.412.46 | 1.96 | 25.46% (+0.50) | |
| Oct 31, 2025 | 2025 (Q3) | 1.601.69 | 2.72 | -38.00% (-1.03) | |
| Jul 31, 2025 | 2025 (Q2) | 2.612.69 | 2.4 | 12.08% (+0.29) | |
| Apr 25, 2025 | 2025 (Q1) | 2.162.23 | 2.1 | 6.49% (+0.14) | |
| Jan 31, 2025 | 2024 (Q4) | 1.921.96 | 2.53 | -22.58% (-0.57) | |
| Oct 30, 2024 | 2024 (Q3) | 2.652.72 | 2.68 | 1.69% (+0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

